Able Innovations
Able Innovations is solving the painful and labour-intensive process of patient transfers by developing innovative robotic technology that enables effortless, contactless, single caregiver, safe and dignified transfers. Their DELTA Platform™, is capable of automated transfers of supine individuals who need to be moved laterally (ex. Bed to stretcher, imaging table) in healthcare facilities. With our front line staff reaching a breaking point, and facilities struggling to balance budgets- the DELTA Platform™ will result in safer working conditions for staff, and more sustainable operations for facilities as they will be able to do more with less.
Presenter: Jayiesh Singh, Chief Executive Officer
Read More
Air Microfluidic Systems Inc. (AMS)
Air Microfluidic Systems Inc. (AMS) is a startup working on developing wearable devices powered by our patent-pending air microfluidics technologies. Our current leading product is an air microfluidics-enabled active compression apparel (AMACA) for treating breast cancer-related lymphedema, which has the state-of-the-art performance while being portable with a smartphone-sized wearable control box. AMACA is at Technology Readiness Level (TRL) 5. We are at the pre-clinical stage focusing on the research and development of AMACA. The proceeds will be used for research and development from the current TRL 5 to TRL 7, pre-clinical trials (TRL 8), and commercialization (TRL 9).
Hear more from this company during the Early Technology Showcase.
Presenter: Run Ze Gao
Read More
AltumView Systems
AltumView is a Vancouver AI company founded in 2016. It develops a smart sensor for applications such as senior care, security, and telehealth. The sensor monitors the activity of people such as seniors, collect health statistics, and notify caregivers when emergencies are detected, while preserving privacy. It has been in the markets of Canada, Japan, China, and Taiwan for one year. The second-generation sensor will be released in early 2021, which recently won the CES 2021 Innovation Award Honoree. The company has raised several rounds of angel funds, and is seeking new capital to scale up manufacturing, marketing, and R&D.
Presenter: Jie Liang, President and CEO
Read More
ARC Medical Devices
ARC is a clinical stage company developing the only liquid medical device that forms a barrier film to prevent surgical adhesions throughout the entire abdominopelvic cavity. Our nonclinical data show superior efficacy compared with three of the top marketed products. We are currently completing a volume escalation, safety clinical trial. Proceeds from our Series B financing will be used to start and complete a US Phase 2 efficacy and safety clinical trial in 100 patients undergoing pelvic/gynecological surgery; prosecute and maintain 8 new patent families and 3 previously issued patent families; and to support manufacturing and market access/reimbursement activities.
Presenter: Chris Springate, CEO
Read More
BresoTEC
BresoTEC has developed a proprietary acoustic and movement-based AI analysis platform that transforms the precision of a sleep laboratory in to a simple, cordless technology for home use. BresoTEC has completed development and will begin clinical trials early in the new year. Use of funds raised are for scale up of marketing, selling and regulatory manufacturing costs for the US market, development of the second version of the BresoDX home sleep test and scaling costs.
Presenter: Peter Bloch, CEO
Read More
Curiato
Curiato is a digital health platform that is leveraging biosensing and AI to deliver patient data and insights directly from the surface of the bed to power an ecosystem of applications such as pressure injuries, heart failure, infectious disease, burns, patient safety and more. One device, multiple clinical software applications. Curiato is post revenue with successful clinical pilots, publications and Health Canada licensed. Curiatio is raising Series A capital to support US market entry, sales & marketing, and creation of additional clinical software applications.
Presenter: Moazam Khan, Co-Founder & CEO
Read More
KA Imaging Inc
KA Imaging has created color x-ray (Reveal™)which allows for soft tissue and bone separation resulting in better patient outcomes. Reveal™, has received USA FDA 510(k) clearance and Health Canada approval and the company is focusing on commercialisation. KA is raising $25M USD for commercialization infrastructure (sales, service and applications), marketing the hardware-as-a-service revenue model and AI development.
Presenter: Amol Karnick, President & CEO
Read More
MY01
MY01 Inc. is on a mission to empower healthcare professionals with the ability to pre-empt severe medical conditions thereby improving patient outcomes. We are commercial and saving limbs with our MY01 Continuous Intracompartment Pressure Monitor.
Presenter: Charles Allan, CEO
Read More
PROTXX
PROTXX enhances care, outcomes, and healthcare economics for patients living with neuro-disruptive (e.g. concussion, stroke) and neuro-degenerative (e.g. multiple sclerosis, Parkinson’s disease) medical conditions. Our precision health platform integrates innovations in non-invasive wearable physiological sensors and machine learning classification of neurosensory and neuromotor impairments, replacing complex clinical equipment and time-consuming tests with easier-to-use, lower-cost, in-clinic and remote precision patient assessments. At the core of the PROTXX platform is the company’s “phybrata” sensor, a tiny, non-invasive device worn behind the ear that is able to classify, quantify, and monitor impairments to the major neurophysiological systems in the body.
Presenter: John Ralston, CEO and Founder
Read More
Spiderwort
Spiderwort is an innovative pre-clinical stage tissue engineering company specializing in the development of cellulose-based biomaterials with a lead indication in Spinal Cord Injury repair with the ultimate goal to improve human quality of life. The FDA has granted a Breakthrough Device Designation for Spiderwort’s spinal cord technology. Spiderwort is raising Series A capital to support clinical pilot studies.
Presenter: Charles Cuerrier, CEO
Read More
Steadiwear
Steadiwear develops battery-free gloves that stabilizes hand tremors in Parkinson’s disease & Essential tremor using technology was inspired by leading-edge earthquake dampers used in buildings. We are raising seed funding for clinical trial & health economics studies, manufacturing, and sales and marketing.
Presenter: Mark Elias, CEO
Read More
Synergy Disc Replacement
SDRi is a Canadian spinal medical device company pioneering a revolutionary artificial disc replacement implant technology - the only artificial disc implant that can both preserve motion and restore alignment to the spine. With a CE mark, Synergy has begun early commercialization efforts in last couple years in Europe and Australia. We have completed more than 1000 implants of the Synergy Disc with no device related adverse events. Synergy is now raising $15M USD to complete its FDA IDE clinical trial in pursuit of USA market approval, the largest market in the world for cervical artificial disc implants.
Presenter: Josh Butters, CEO
Read More
VitalTracer
VitalTracer is a start-up whose focus is on healthcare in the domain of personalized medicine. We aim to create a platform for those who need to improve or manage health with a convenient and non-invasive solution. VitalTracer has raised about 1 million in non-dilutive financing and is currently boot-strapping. We will open our seed round in summer 2021 which will cover our expenses of Research and Development, Regulatory clearance for Health Canada and FDA, manufacturing and clinical validation.
Presenter: Azadeh Dastmalchi, CEO
Read More
